We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Akcea Therapeutics Inc | NASDAQ:AKCA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.17 | 18.08 | 19.00 | 0 | 01:00:00 |
Delaware
|
001-38137
|
47-2608175
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
55 Cambridge Parkway
Suite 100
Cambridge, Massachusetts
|
02142
|
(Address of principal executive offices)
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
|
Exhibit No.
|
Description
|
|
Consent of Independent Registered Public Accounting Firm
|
||
Updates, where applicable, to Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, from Akcea Therapeutic, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2017, as filed with the Securities and Exchange Commission on
February 28, 2018
|
||
Updated Part II, Item 8. Financial Statements and Supplementary Data, from Akcea Therapeutic, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2017, as filed with the Securities and Exchange Commission on
February 28, 2018
|
||
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase
|
AKCEA THERAPEUTICS, INC.
|
||
Date: September 18, 2018
|
By:
|
/s/ Paula Soteropoulos
|
Paula Soteropoulos
|
||
Chief Executive Officer
|
1 Year Akcea Therapeutics Chart |
1 Month Akcea Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions